BCM

Boxer Capital Management Portfolio holdings

AUM $199M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
-$134M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
36
New
Increased
Reduced
Closed

Top Buys

1
+$8.23M
2
+$7.88M
3
+$7.32M
4
KYMR icon
Kymera Therapeutics
KYMR
+$4.67M
5
REPL icon
Replimune Group
REPL
+$3.86M

Top Sells

1
+$31.9M
2
+$25.5M
3
+$24.2M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$20.1M
5
RVMD icon
Revolution Medicines
RVMD
+$19.3M

Sector Composition

1 Healthcare 99.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$1.02B
$50M 25.18%
9,771,485
-609,514
RVMD icon
2
Revolution Medicines
RVMD
$9.29B
$29.2M 14.69%
792,977
-525,000
REPL icon
3
Replimune Group
REPL
$365M
$20.5M 10.34%
2,211,341
+415,000
MRUS icon
4
Merus
MRUS
$7.19B
$19.2M 9.66%
365,000
-335,000
KYMR icon
5
Kymera Therapeutics
KYMR
$4.32B
$18.9M 9.49%
432,010
+107,010
QURE icon
6
uniQure
QURE
$3.7B
$12.5M 6.31%
899,500
+149,500
ITOS
7
DELISTED
iTeos Therapeutics
ITOS
$8.23M 4.14%
+825,000
URGN icon
8
UroGen Pharma
URGN
$783M
$7.88M 3.97%
+575,000
AMLX icon
9
Amylyx Pharmaceuticals
AMLX
$1.62B
$7.85M 3.95%
1,225,000
-525,000
CBIO
10
Crescent Biopharma
CBIO
$207M
$7.32M 3.69%
+453,686
PTGX icon
11
Protagonist Therapeutics
PTGX
$4.71B
$3.32M 1.67%
+60,000
NKTR icon
12
Nektar Therapeutics
NKTR
$1.05B
$3.23M 1.63%
+125,000
KOD icon
13
Kodiak Sciences
KOD
$788M
$2.8M 1.41%
750,000
-285,000
CDTX icon
14
Cidara Therapeutics
CDTX
$2.59B
$2.68M 1.35%
+55,000
NRIX icon
15
Nurix Therapeutics
NRIX
$771M
$1.99M 1%
175,000
-388,067
TIL icon
16
Instil Bio
TIL
$136M
$1.47M 0.74%
70,700
-9,425
KALV icon
17
KalVista Pharmaceuticals
KALV
$558M
$1.06M 0.53%
+93,400
SRPT icon
18
Sarepta Therapeutics
SRPT
$2.44B
$428K 0.22%
+25,000
NUVB.WS icon
19
Nuvation Bio Inc Warrants
NUVB.WS
$56.1M
$72K 0.04%
266,666
SRZNW icon
20
Surrozen Inc Warrant
SRZNW
$39.5K
$1.21K ﹤0.01%
66,666
ANAB icon
21
AnaptysBio
ANAB
$962M
– –
-1,300,000
APLS icon
22
Apellis Pharmaceuticals
APLS
$3.05B
– –
-713,000
DAWN icon
23
Day One Biopharmaceuticals
DAWN
$765M
– –
-1,189,943
DNLI icon
24
Denali Therapeutics
DNLI
$2.44B
– –
-250,000
ELVN icon
25
Enliven Therapeutics
ELVN
$1.29B
– –
-671,358
1
2